Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.
Junichi Nishimura, Taroh Satoh, Mutsumi Fukunaga, Hiroyoshi Takemoto, Ken Nakata, Yoshihito Ide, Takayuki Fukuzaki, Toshihiro Kudo, Yasuhiro Miyake, Masayoshi Yasui, Shunji Morita, Daisuke Sakai, Mamoru Uemura, Taishi Hata, Ichiro Takemasa, Tsunekazu Mizushima, Yuko Ohno, Hirofumi Yamamoto, Mitsugu Sekimoto, Riichiro Nezu, Yuichiro Doki, Masaki Mori
European journal of cancer (Oxford, England : 1990) 2015;51(10):1274-82